+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The miracle drug for women with heart failure may be testosterone. The hormone treatment may help patients recover some of the energy and strength lost because of their heart conditions



The miracle drug for women with heart failure may be testosterone. The hormone treatment may help patients recover some of the energy and strength lost because of their heart conditions



Heart Advisor 14(1): 7-7




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056407687

Download citation: RISBibTeXText

PMID: 22973593


Related references

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. European Heart Journal 26(24): 2706-2713, 2005

Cardiac resynchronization therapy results in improvement in echocardiographic parameters in heart failure patients Evidence from MIRACLE and MIRACLE ICD trials. Circulation 106(19 Supplement): II 380, November 5, 2002

Erythrocyte acid resistance in the drug treatment of heart failure in patients with ischemic heart disease. Vrachebnoe Delo 1991(5): 33-35, 1991

Effects of testosterone on oxygen uptake, insulin resistance and muscle strength in elderly patients with chronic heart failure. 2007

Drug therapy of heart disease in pediatric patients. II. The treatment of congestive heart failure in infants and children with digitalis preparations. American Heart Journal 86(2): 270-275, 1973

Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. American Heart Journal 151(4): 837-843, 2006

Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure. Circulation. Heart Failure 10(9), 2017

Growth hormone addition for patients with congestive heart failure A randomized, placebo controlled study with recombinant human growth hormone in patients with congestive heart failure and without growth hormone deficiency. Journal of the American College of Cardiology 31(2 SUPPL A): 249A, 1998

Assessment of dyssynchrony in patients with severe heart failure by nuclear imaging: paradise lost and regained or lost and gone forever?. Italian Heart Journal 6(2): 96-105, 2005

Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial). American Journal of Cardiology 95(4): 529-532, 2005

Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. Paediatric Drugs 18(2): 89-99, 2016

Combination drug therapy in chronic heart failure: Is treatment part of the problem in heart failure?. Cardiovascular Drugs and Therapy 11(SUPPL. 1): 297-303, 1997

Treatment of heart failure--role of biventricular pacing for heart failure not responding well to drug therapy. Singapore Medical Journal 44(3): 114-122, 2003

Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clinical Cardiology 23(12): 909-914, 2000

Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support. European Journal of Heart Failure 20(1): 164-174, 2017